Impact of the COVID-19 Pandemic on Diabetic Foot Patients A Shift in the Infectious Agent Profile Toward Nonfermentative Gram-Negative Bacilli
dc.authorscopusid | 55777973900 | |
dc.authorscopusid | 59252636500 | |
dc.authorscopusid | 6602738477 | |
dc.authorscopusid | 9248677100 | |
dc.authorscopusid | 59236059200 | |
dc.authorscopusid | 6507180529 | |
dc.authorscopusid | 59236049700 | |
dc.contributor.author | Tülek, Necla | |
dc.contributor.author | Saltoğglu,N. | |
dc.contributor.author | Acar, Ali | |
dc.contributor.author | Turhan,Ö. | |
dc.contributor.author | Serin,E.N. | |
dc.contributor.author | Yapar,D. | |
dc.contributor.author | Kaya,S.D. | |
dc.contributor.other | Basic Sciences | |
dc.date.accessioned | 2024-09-10T21:35:57Z | |
dc.date.available | 2024-09-10T21:35:57Z | |
dc.date.issued | 2024 | |
dc.department | Atılım University | en_US |
dc.department-temp | Acar A., Department of Medical Microbiology, Atılım University School of Medicine, Ankara, Turkey, Bayındır Healthcare Group, Infectious Diseases Clinic, Sogutozu Hospital, Ankara, Turkey; Saltoğglu N., Department of Infectious Diseases and Clinical Microbiology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey; Tülek N., Department of Medical Microbiology, Atılım University School of Medicine, Ankara, Turkey; Turhan Ö., Department of Infectious Diseases and Clinical Microbiology, Akdeniz University School of Medicine, Antalya, Turkey; Serin E.N., Department of Endocrinology, Akdeniz University School of Medicine, Antalya, Turkey; Yapar D., Department of Infectious Diseases and Clinical Microbiology, Hitit University School of Medicine, Çorum, Ulukavak, Turkey; Kendirci M., Department of General Surgery, Hitit University School of Medicine, Çorum, Ulukavak, Turkey; Sürme S., Department of Infectious Diseases and Clinical Microbiology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey; Karaca B.Y., Department of Infectious Diseases and Clinical Microbiology, Izmir Katip Çelebi University Faculty of Medicine, Izmir, Çiğgli, Turkey; Altay F.A., Department of Infectious Diseases and Clinical Microbiology, Health Sciences University Dısşkapı Yıldırım Beyazıt Teaching and Research Hospital, Ankara, Turkey; Taysşi R., Department of Infectious Diseases and Clinical Microbiology, Health Sciences University Dısşkapı Yıldırım Beyazıt Teaching and Research Hospital, Ankara, Turkey; Sşencan I., Department of Infectious Diseases and Clinical Microbiology, Health Sciences University Dısşkapı Yıldırım Beyazıt Teaching and Research Hospital, Ankara, Turkey; Tanyel E., Department of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis University Faculty of Medicine, Samsun, Atakum, Turkey; Bilek H.C., Department of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis University Faculty of Medicine, Samsun, Atakum, Turkey; Güler Ö., Department of Infectious Diseases and Clinical Microbiology, Medical Faculty, Kocaeli University, Kocaeli, Izmit, Turkey; Mutlu B., Department of Infectious Diseases and Clinical Microbiology, Medical Faculty, Kocaeli University, Kocaeli, Izmit, Turkey; Aksan T., Department of Plastic and Reconstructive Surgery, Faculty of Medicine, Istanbul Medeniyet University, Goztepe Training and Research Hospital, Kadıköy, Istanbul, Turkey; Karadağg F.Y., Department of Plastic and Reconstructive Surgery, Faculty of Medicine, Istanbul Medeniyet University, Goztepe Training and Research Hospital, Kadıköy, Istanbul, Turkey; Kadanalı A., Department of Infectious Diseases and Clinical Microbiology, Biruni University, Medical School, Zeytinburnu, Istanbul, Turkey, Department of Infectious Diseases and Clinical Microbiology, Istanbul Umraniye Training and Research Hospital, Ümraniye, Istanbul, Turkey; Altunal L.N., Department of Infectious Diseases and Clinical Microbiology, Istanbul Umraniye Training and Research Hospital, Ümraniye, Istanbul, Turkey; Oglu M.C., Department of Infectious Diseases and Clinical Microbiology, Biruni University, Medical School, Zeytinburnu, Istanbul, Turkey; Sşenbayrak S., Department of Infectious Diseases and Clinical Microbiology, Health Sciences University Haydarpasşa Numune Training and Research Hospital, Istanbul, Turkey; Erol S., Department of Infectious Diseases and Clinical Microbiology, Health Sciences University Haydarpasşa Numune Training and Research Hospital, Istanbul, Turkey; Ak Ö., Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Kütahya Health Sciences University, Kütahya, Zafertepe, Turkey; Aladağg N., Department of Internal Medicine, Health Sciences University, Kartal Dr. Lütfi Kirdar Training and Research Hospital, Kartal, Istanbul, Turkey; Demirtürk N., Department of Infectious Diseases and Clinical Microbiology, Medical Faculty, Afyon Saglik Bilimleri University, Afyon, Turkey; Konya P., Department of Infectious Diseases and Clinical Microbiology, Medical Faculty, Afyon Saglik Bilimleri University, Afyon, Turkey; Bulut D., Department of Infectious Diseases and Clinical Microbiology, Van Training and Research Hospital, Van, Edremit, Turkey; Engin D.Ö., Department of Infectious Diseases and Clinical Microbiology, Fatih Sultan Mehmet Training and Research Hospital, Atasşehir, Istanbul, Turkey; Aslan H.M., Department of Cardiac Surgery, Fatih Sultan Mehmet Training and Research Hospital, Atasşehir, Istanbul, Turkey; Kaya S.D., Department of Infectious Diseases and Clinical Microbiology, Kosşuyolu High Specialization Education and Research Hospital, Kartal, Istanbul, Turkey | en_US |
dc.description.abstract | Background: Diabetes foot infection is a very important public health problem that causes serious health problems, mortality, and high health expenditures, and is one of the most important complications of diabetes mellitus. There are concerns that approaches such as limited personal visits to doctors, avoidance of hospitals, and restrictions on nonemergency surgical procedures during the coronavirus disease of 2019 pandemic pose a threat to those with diabetic foot problems, including diabetic foot ulcers (DFUs), ischemia, and infection, resulting in increased limb loss and mortality. Methods: This multicenter, retrospective, cross-sectional study was conducted in 14 tertiary care hospitals from various regions of Turkey. A total of 1,394 patient records were evaluated, 794 of which were between January 1, 2019, and January 30, 2020 (prepandemic [Pre-P]), and 605 of which were between February 1, 2020, and February 28, 2021 (pandemic period [PP]). Results: During the PP, diabetic foot patient follow-up decreased by 23.8%. In addition, the number of hospitalizations attributable to DFU has decreased significantly during the PP (P = .035). There was no difference between the groups regarding patient demographics, medical history, DFU severity, biochemical and radiologic findings, or comorbidities, but the mean duration of diabetes mellitus years was longer in patients in the Pre-P than in those in the PP (15.1 years versus 13.7 years). There was no difference between the two groups in terms of major complications such as limb loss and mortality, but infection recurrence was higher in the PP than in the Pre-P (12.9% versus 11.4%; P < .05). The prevalence of nonfermentative gram-negative bacteria as causative agents in DFU infections increased during the PP. In particular, the prevalence of carbapenem-resistant Pseudomonas spp. increased statistically during the PP. Conclusions: The rapid adaptation to the pandemic with the measures and changes developed by the multidisciplinary diabetic foot care committees may be the reasons why there was no increase in complications because of DFU during the pandemic in Turkey. © 2024, American Podiatric Medical Association. All rights reserved. | en_US |
dc.identifier.citation | 0 | |
dc.identifier.doi | 10.7547/22-073 | |
dc.identifier.issn | 8750-7315 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 39058633 | |
dc.identifier.scopus | 2-s2.0-85199723888 | |
dc.identifier.scopusquality | Q3 | |
dc.identifier.uri | https://doi.org/10.7547/22-073 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14411/7393 | |
dc.identifier.volume | 114 | en_US |
dc.identifier.wosquality | Q4 | |
dc.language.iso | en | en_US |
dc.publisher | American Podiatric Medical Association | en_US |
dc.relation.ispartof | Journal of the American Podiatric Medical Association | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [No Keyword Available] | en_US |
dc.title | Impact of the COVID-19 Pandemic on Diabetic Foot Patients A Shift in the Infectious Agent Profile Toward Nonfermentative Gram-Negative Bacilli | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 1c88d5b4-a457-4b19-909d-82f2966eb2fa | |
relation.isAuthorOfPublication | 3c0e93fc-6f64-486e-8d88-93d616e547ed | |
relation.isAuthorOfPublication.latestForDiscovery | 1c88d5b4-a457-4b19-909d-82f2966eb2fa | |
relation.isOrgUnitOfPublication | c6d3b3b7-f103-4779-9789-92b2e2420f2d | |
relation.isOrgUnitOfPublication.latestForDiscovery | c6d3b3b7-f103-4779-9789-92b2e2420f2d |